ID   NCC-SS4-C1
AC   CVCL_A6FC
DR   Wikidata; Q107116531
RX   PubMed=33611700;
WW   https://en.cellline.jp/product/ncc-ss4-c1/
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo T.).
CC   Doubling time: ~245 hours (PubMed=33611700).
CC   Sequence variation: Gene fusion; HGNC; 11340; SS18 + HGNC; 11335; SSX1; Name(s)=SS18-SSX1 (PubMed=33611700).
CC   Omics: SNP array analysis.
ST   Source(s): PubMed=33611700
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 9
ST   D21S11: 29,30
ST   D5S818: 10,11
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17,20
DI   NCIt; C3400; Synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 5
//
RX   PubMed=33611700; DOI=10.1007/s13577-021-00509-z;
RA   Tsuchiya R., Yoshimatsu Y., Noguchi R., Ono T., Sei A., Takeshita F.,
RA   Sugaya J., Iwata S., Yoshida A., Ohtori S., Kawai A., Kondo T.;
RT   "Establishment and characterization of NCC-SS4-C1: a novel
RT   patient-derived cell line of synovial sarcoma.";
RL   Hum. Cell 34:998-1007(2021).
//